药物动力学服务市场：按类型、按应用划分 - 2023-2030 年全球预测

药物动力学服务市场预计将从 2022 年的 9.7637 亿美元增至 2030 年的 17.1229 亿美元，预测期内年复合成长率为 7.27%。

全球药物动力学服务市场

FPNV定位矩阵

FPNV 定位矩阵是评估药物动力学服务市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.药物动力学服务市场的市场规模与预测是多少？

2.药物动力学服务市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.药物动力学服务市场的竞争策略窗口有哪些？

4.药物动力学服务市场的最新技术趋势和法律规范是什么？

5.药物动力学服务市场主要供应商的市场占有率是多少？

6. 进入药物动力学服务市场的合适型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 个体化个人化医疗的需求需要个人化的药物动力学评估
    • 对具有成本效益的药物开发和临床试验设计的需求不断增加
    • 政府对药物动力学研究和服务的支持
  • 抑制因素
    • 开发需要药物药物动力学评估的新药成本高昂
  • 机会
    • 引进药物动力学动力学先进技术
    • 扩大预测分析的使用，以提高基于 PK资料的预测的效率和准确性
  • 任务
    • 与药物动力学服务相关的药物和治疗方法核准的严格法规要求
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第6章药物动力学服务市场：依类型

• 大分子药物动力学服务
• 小分子药物药物动力学服务

第7章药物动力学服务市场：按应用

• 大公司
• 中小企业

第8章美洲药物药物动力学服务市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太药物药物动力学服务市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲药物动力学服务市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • Absorption Systems LLC
  • Allucent
  • Aurigene Pharmaceutical Services Ltd.
  • Certara
  • Charles River Laboratories, Inc.
  • Creative Bioarray
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Laboratories, Inc.
  • ICON PLC
  • Laboratory Corporation of America Holdings
  • LGC Limited
  • NUVISAN Pharma Holding GmbH
  • Pacific BioLabs
  • Parexel International（MA）Corporation
  • Pfizer Inc.
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Premier Consulting
  • Reaction Biology Corporation
  • SGS SA
  • Svar Life Science AB
  • WuXi AppTec Co., Ltd.
  • XenoTech
  • Xyzagen
• 主要产品系列

第13章附录

• 讨论指南
• 关于许可证和定价

The Pharmacokinetics Services Market is projected to reach USD 1,712.29 million by 2030 from USD 976.37 million in 2022, at a CAGR of 7.27% during the forecast period.

Global Pharmacokinetics Services Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pharmacokinetics Services Market.

Based on Type, market is studied across Large Molecules Pharmacokinetics Services and Small Molecules Pharmacokinetics Services. The Small Molecules Pharmacokinetics Services is projected to witness significant market share during forecast period.

Based on Application, market is studied across Large Enterprise and Small and Medium Enterprise. The Large Enterprise is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pharmacokinetics Services Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pharmacokinetics Services Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pharmacokinetics Services Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Allucent, Aurigene Pharmaceutical Services Ltd., Certara, Charles River Laboratories, Inc., Creative Bioarray, Eurofins Scientific SE, Evotec SE, Frontage Laboratories, Inc., ICON PLC, Laboratory Corporation of America Holdings, LGC Limited, NUVISAN Pharma Holding GmbH, Pacific BioLabs, Parexel International (MA) Corporation, Pfizer Inc., PPD Inc. by Thermo Fisher Scientific Inc., Premier Consulting, Reaction Biology Corporation, SGS SA, Svar Life Science AB, WuXi AppTec Co., Ltd., XenoTech, and Xyzagen.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Pharmacokinetics Services Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Pharmacokinetics Services Market?

3. What is the competitive strategic window for identifying opportunities in the Pharmacokinetics Services Market?

4. What are the latest technology trends and regulatory frameworks in the Pharmacokinetics Services Market?

5. What is the market share of the leading vendors in the Pharmacokinetics Services Market?

6. Which modes and strategic moves are suitable for entering the Pharmacokinetics Services Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pharmacokinetics Services Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand for personalized medicine that requires personalized pharmacokinetic assessments
    • 5.1.1.2. Increased demand for cost-effective drug development and clinical trial designs
    • 5.1.1.3. Government support for pharmacokinetics research and services
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with the development of novel drugs that require pharmacokinetic assessment
  • 5.1.3. Opportunities
    • 5.1.3.1. Implementation of advanced technologies in pharmacokinetics
    • 5.1.3.2. Growing use of predictive analytics to improve efficiency and accuracy of predictions based on PK data
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for the approval of drugs and therapies related to pharmacokinetics services
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Pharmacokinetics Services Market, by Type

• 6.1. Introduction
• 6.2. Large Molecules Pharmacokinetics Services
• 6.3. Small Molecules Pharmacokinetics Services

7. Pharmacokinetics Services Market, by Application

• 7.1. Introduction
• 7.2. Large Enterprise
• 7.3. Small and Medium Enterprise

8. Americas Pharmacokinetics Services Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Pharmacokinetics Services Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Pharmacokinetics Services Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Absorption Systems LLC
  • 12.1.2. Allucent
  • 12.1.3. Aurigene Pharmaceutical Services Ltd.
  • 12.1.4. Certara
  • 12.1.5. Charles River Laboratories, Inc.
  • 12.1.6. Creative Bioarray
  • 12.1.7. Eurofins Scientific SE
  • 12.1.8. Evotec SE
  • 12.1.9. Frontage Laboratories, Inc.
  • 12.1.10. ICON PLC
  • 12.1.11. Laboratory Corporation of America Holdings
  • 12.1.12. LGC Limited
  • 12.1.13. NUVISAN Pharma Holding GmbH
  • 12.1.14. Pacific BioLabs
  • 12.1.15. Parexel International (MA) Corporation
  • 12.1.16. Pfizer Inc.
  • 12.1.17. PPD Inc. by Thermo Fisher Scientific Inc.
  • 12.1.18. Premier Consulting
  • 12.1.19. Reaction Biology Corporation
  • 12.1.20. SGS SA
  • 12.1.21. Svar Life Science AB
  • 12.1.22. WuXi AppTec Co., Ltd.
  • 12.1.23. XenoTech
  • 12.1.24. Xyzagen
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. PHARMACOKINETICS SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACOKINETICS SERVICES MARKET SIZE, 2022 VS 2030
• FIGURE 3. PHARMACOKINETICS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. PHARMACOKINETICS SERVICES MARKET DYNAMICS
• FIGURE 7. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 8. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 10. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 12. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 14. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. PHARMACOKINETICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 20. PHARMACOKINETICS SERVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PHARMACOKINETICS SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PHARMACOKINETICS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACOKINETICS SERVICES MARKET SIZE, BY LARGE MOLECULES PHARMACOKINETICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PHARMACOKINETICS SERVICES MARKET SIZE, BY SMALL MOLECULES PHARMACOKINETICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. PHARMACOKINETICS SERVICES MARKET SIZE, BY LARGE ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PHARMACOKINETICS SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 14. ARGENTINA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. ARGENTINA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. BRAZIL PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. BRAZIL PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. CANADA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. CANADA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. MEXICO PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. MEXICO PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 25. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. AUSTRALIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AUSTRALIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CHINA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CHINA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. INDIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. INDIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDONESIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDONESIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. JAPAN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. JAPAN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MALAYSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MALAYSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. PHILIPPINES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. PHILIPPINES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. SINGAPORE PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. SINGAPORE PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SOUTH KOREA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SOUTH KOREA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. TAIWAN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. TAIWAN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. THAILAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. THAILAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. VIETNAM PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. VIETNAM PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. DENMARK PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. DENMARK PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EGYPT PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EGYPT PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. FINLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. FINLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FRANCE PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FRANCE PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. GERMANY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. GERMANY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ISRAEL PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ISRAEL PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ITALY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ITALY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. NETHERLANDS PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. NETHERLANDS PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NIGERIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NIGERIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NORWAY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NORWAY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. POLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. POLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. QATAR PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. QATAR PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. RUSSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. RUSSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. SAUDI ARABIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SAUDI ARABIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SPAIN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SPAIN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SWEDEN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SWEDEN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWITZERLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWITZERLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TURKEY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TURKEY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. UNITED ARAB EMIRATES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED ARAB EMIRATES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED KINGDOM PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED KINGDOM PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHARMACOKINETICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 98. PHARMACOKINETICS SERVICES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 99. PHARMACOKINETICS SERVICES MARKET LICENSE & PRICING